<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33339852</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>07</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Dec</Month><Day>18</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>The RabGEF ALS2 is a hypoxia inducible target associated with the acquisition of aggressive traits in tumor cells.</ArticleTitle><Pagination><StartPage>22302</StartPage><MedlinePgn>22302</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">22302</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-020-79270-6</ELocationID><Abstract><AbstractText>Tumor hypoxia and the hypoxia inducible factor-1, HIF-1, play critical roles in cancer progression and metastasis. We previously showed that hypoxia activates the endosomal GTPase Rab5, leading to tumor cell migration and invasion, and that these events do not involve changes in Rab protein expression, suggesting the participation of intermediate activators. Here, we identified ALS2, a guanine nucleotide exchange factor that is upregulated in cancer, as responsible for increased Rab5-GTP loading, cell migration and metastasis in hypoxia. Specifically, hypoxia augmented ALS2 mRNA and protein levels, and these events involved HIF-1&#x3b1;-dependent transcription, as shown by RNAi, pharmacological inhibition, chromatin immunoprecipitation and bioinformatics analyses, which identified a functional HIF-1&#x3b1;-binding site in the proximal promoter region of ALS2. Moreover, ALS2 and Rab5 activity were elevated both in a model of endogenous HIF-1&#x3b1; stabilization (renal cell carcinoma) and by following expression of stable non-hydroxylatable HIF-1&#x3b1;. Strikingly, ALS2 upregulation in hypoxia was required for Rab5 activation, tumor cell migration and invasion, as well as experimental metastasis in C57BL/6 mice. Finally, immunohistochemical analyses in patient biopsies with renal cell carcinoma showed that elevated HIF-1&#x3b1; correlates with increased ALS2 expression. Hence, this study identifies ALS2 as a novel hypoxia-inducible gene associated with tumor progression and metastasis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rivas</LastName><ForeName>Solange</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Research in Dental Sciences, Faculty of Dentistry, Universidad de Chile, Calle Sergio Livingstone 943, Independencia, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Patricio</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute for Research in Dental Sciences, Faculty of Dentistry, Universidad de Chile, Calle Sergio Livingstone 943, Independencia, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reyes</LastName><ForeName>Montserrat</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathology and Oral Medicine, Faculty of Dentistry, Universidad de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sep&#xfa;lveda</LastName><ForeName>Hugo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences and FONDAP Center for Genome Regulation, Faculty of Medicine and Faculty of Life Sciences, Universidad Andr&#xe9;s Bello, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solano</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute for Research in Dental Sciences, Faculty of Dentistry, Universidad de Chile, Calle Sergio Livingstone 943, Independencia, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acu&#xf1;a</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratory of Pathological Anatomy, Hospital San Jos&#xe9;, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guerrero</LastName><ForeName>Marisol</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Pathological Anatomy, Hospital San Jos&#xe9;, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varas-Godoy</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Cell Biology and Biomedicine (CEBICEM), Faculty of Medicine and Science, Universidad San Sebasti&#xe1;n, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quest</LastName><ForeName>Andrew F G</ForeName><Initials>AFG</Initials><AffiliationInfo><Affiliation>Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Studies on Exercise, Metabolism and Cancer (CEMC), Biomedical Sciences Institute (ICBM), Faculty of Medicine, Universidad de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montecino</LastName><ForeName>Mart&#xed;n</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences and FONDAP Center for Genome Regulation, Faculty of Medicine and Faculty of Life Sciences, Universidad Andr&#xe9;s Bello, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres</LastName><ForeName>Vicente A</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>Institute for Research in Dental Sciences, Faculty of Dentistry, Universidad de Chile, Calle Sergio Livingstone 943, Independencia, Santiago, Chile. vatorres@odontologia.uchile.cl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile, Santiago, Chile. vatorres@odontologia.uchile.cl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C512358">Als2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020662">Guanine Nucleotide Exchange Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497443">Hif1a protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051795">Hypoxia-Inducible Factor 1, alpha Subunit</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.5.2</RegistryNumber><NameOfSubstance UI="D020696">rab5 GTP-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C565957">Amyotrophic Lateral Sclerosis 2, Juvenile</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002292" MajorTopicYN="N">Carcinoma, Renal Cell</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002465" MajorTopicYN="N">Cell Movement</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020662" MajorTopicYN="N">Guanine Nucleotide Exchange Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051795" MajorTopicYN="N">Hypoxia-Inducible Factor 1, alpha Subunit</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009361" MajorTopicYN="N">Neoplasm Invasiveness</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015533" MajorTopicYN="N">Transcriptional Activation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072258" MajorTopicYN="N">Tumor Hypoxia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020696" MajorTopicYN="N">rab5 GTP-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>19</Day><Hour>5</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33339852</ArticleId><ArticleId IdType="pmc">PMC7749157</ArticleId><ArticleId IdType="doi">10.1038/s41598-020-79270-6</ArticleId><ArticleId IdType="pii">10.1038/s41598-020-79270-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schito L, Semenza GL. Hypoxia-inducible factors: master regulators of cancer progression. Trends Cancer. 2016;2:758&#x2013;770. doi: 10.1016/j.trecan.2016.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trecan.2016.10.016</ArticleId><ArticleId IdType="pubmed">28741521</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakazawa MS, Keith B, Simon MC. Oxygen availability and metabolic adaptations. Nat. Rev. Cancer. 2016;16:663&#x2013;673. doi: 10.1038/nrc.2016.84.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc.2016.84</ArticleId><ArticleId IdType="pmc">PMC5546320</ArticleId><ArticleId IdType="pubmed">27658636</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, et al. Regulation of endocytosis via the oxygen-sensing pathway. Nat. Med. 2009;15:319&#x2013;324. doi: 10.1038/nm.1922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1922</ArticleId><ArticleId IdType="pubmed">19252501</ArticleId></ArticleIdList></Reference><Reference><Citation>Rankin EB, Giaccia AJ. Hypoxic control of metastasis. Science. 2016;352:175&#x2013;180. doi: 10.1126/science.aaf4405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf4405</ArticleId><ArticleId IdType="pmc">PMC4898055</ArticleId><ArticleId IdType="pubmed">27124451</ArticleId></ArticleIdList></Reference><Reference><Citation>Rankin EB, Giaccia AJ. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ. 2008;15:678&#x2013;685. doi: 10.1038/cdd.2008.21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2008.21</ArticleId><ArticleId IdType="pmc">PMC3050610</ArticleId><ArticleId IdType="pubmed">18259193</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson CM, Ohh M. The multifaceted von Hippel-Lindau tumour suppressor protein. FEBS Lett. 2014;588:2704&#x2013;2711. doi: 10.1016/j.febslet.2014.02.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2014.02.026</ArticleId><ArticleId IdType="pubmed">24583008</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva P, et al. Hypoxia promotes Rab5 activation, leading to tumor cell migration, invasion and metastasis. Oncotarget. 2016;7:29548&#x2013;29562. doi: 10.18632/oncotarget.8794.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.8794</ArticleId><ArticleId IdType="pmc">PMC5045416</ArticleId><ArticleId IdType="pubmed">27121131</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H, et al. Hypoxia stimulates invasion and migration of human cervical cancer cell lines HeLa/SiHa through the Rab11 trafficking of integrin alphavbeta3/FAK/PI3K pathway-mediated Rac1 activation. J. Biosci. 2017;42:491&#x2013;499. doi: 10.1007/s12038-017-9699-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12038-017-9699-0</ArticleId><ArticleId IdType="pubmed">29358562</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon SO, Shin S, Mercurio AM. Hypoxia stimulates carcinoma invasion by stabilizing microtubules and promoting the Rab11 trafficking of the alpha6beta4 integrin. Cancer Res. 2005;65:2761&#x2013;2769. doi: 10.1158/0008-5472.CAN-04-4122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-04-4122</ArticleId><ArticleId IdType="pubmed">15805276</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilkes DM, et al. Hypoxia-inducible factors mediate coordinated RhoA-ROCK1 expression and signaling in breast cancer cells. Proc. Natl. Acad. Sci. USA. 2014;111:E384&#x2013;393. doi: 10.1073/pnas.1321510111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1321510111</ArticleId><ArticleId IdType="pmc">PMC3903228</ArticleId><ArticleId IdType="pubmed">24324133</ArticleId></ArticleIdList></Reference><Reference><Citation>Stenmark H. Rab GTPases as coordinators of vesicle traffic. Nat. Rev. Mol. Cell Biol. 2009;10:513&#x2013;525. doi: 10.1038/nrm2728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2728</ArticleId><ArticleId IdType="pubmed">19603039</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang P, Zhao Z, Tian H, Zhang X. RIN1 exhibits oncogenic property to suppress apoptosis and its aberrant accumulation associates with poor prognosis in melanoma. Tumour Biol. 2012;33:1511&#x2013;1518. doi: 10.1007/s13277-012-0402-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13277-012-0402-7</ArticleId><ArticleId IdType="pubmed">22627834</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng ZH, et al. RIN1 promotes renal cell carcinoma malignancy by activating EGFR signaling through Rab25. Cancer Sci. 2017;108:1620&#x2013;1627. doi: 10.1111/cas.13297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cas.13297</ArticleId><ArticleId IdType="pmc">PMC5543468</ArticleId><ArticleId IdType="pubmed">28612496</ArticleId></ArticleIdList></Reference><Reference><Citation>Izykowska K, et al. Submicroscopic genomic rearrangements change gene expression in T-cell large granular lymphocyte leukemia. Eur. J. Haematol. 2014;93:143&#x2013;149. doi: 10.1111/ejh.12318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejh.12318</ArticleId><ArticleId IdType="pubmed">24649974</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Lu A, Chen X, Wei L, Ding J. RABEX-5 is upregulated and plays an oncogenic role in gastric cancer development by activating the VEGF signaling pathway. PLoS ONE. 2014;9:e113891. doi: 10.1371/journal.pone.0113891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0113891</ArticleId><ArticleId IdType="pmc">PMC4245226</ArticleId><ArticleId IdType="pubmed">25427001</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, et al. Elevated RABEX-5 expression predicts poor prognosis in non-small-cell lung cancer. Am. J. Cancer Res. 2015;5:2849&#x2013;2855.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4633911</ArticleId><ArticleId IdType="pubmed">26609490</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Zhang M, Hu G, Cai Q, Xu T. Elevated RABEX-5 protein expression predicts poor prognosis in combined small cell lung cancer. Tumour Biol. 2015;36:8287&#x2013;8293. doi: 10.1007/s13277-015-3562-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13277-015-3562-4</ArticleId><ArticleId IdType="pubmed">26002576</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang JS, Yang LQ, Du BR, Gao H. Higher RABEX-5 mRNA predicts unfavourable survival in patients with colorectal cancer. Eur. Rev. Med. Pharmacol. Sci. 2017;21:2372&#x2013;2376.</Citation><ArticleIdList><ArticleId IdType="pubmed">28617553</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu F, et al. Rab5 and Alsin regulate stress-activated cytoprotective signaling on mitochondria. Elife. 2018 doi: 10.7554/eLife.32282.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.32282</ArticleId><ArticleId IdType="pmc">PMC5847334</ArticleId><ArticleId IdType="pubmed">29469808</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz J, et al. Rab5 is required in metastatic cancer cells for Caveolin-1-enhanced Rac1 activation, migration and invasion. J. Cell Sci. 2014;127:2401&#x2013;2406. doi: 10.1242/jcs.141689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.141689</ArticleId><ArticleId IdType="pmc">PMC4074264</ArticleId><ArticleId IdType="pubmed">24659799</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendoza P, et al. Rab5 activation promotes focal adhesion disassembly, migration and invasiveness in tumor cells. J. Cell Sci. 2013;126:3835&#x2013;3847. doi: 10.1242/jcs.119727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.119727</ArticleId><ArticleId IdType="pmc">PMC4074302</ArticleId><ArticleId IdType="pubmed">23813952</ArticleId></ArticleIdList></Reference><Reference><Citation>Topp JD, Gray NW, Gerard RD, Horazdovsky BF. Alsin is a Rab5 and Rac1 guanine nucleotide exchange factor. J. Biol. Chem. 2004;279:24612&#x2013;24623. doi: 10.1074/jbc.M313504200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M313504200</ArticleId><ArticleId IdType="pubmed">15033976</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagen T, Taylor CT, Lam F, Moncada S. Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha. Science. 2003;302:1975&#x2013;1978. doi: 10.1126/science.1088805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1088805</ArticleId><ArticleId IdType="pubmed">14671307</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres VA, Mielgo A, Barila D, Anderson DH, Stupack D. Caspase 8 promotes peripheral localization and activation of Rab5. J. Biol. Chem. 2008;283:36280&#x2013;36289. doi: 10.1074/jbc.M805878200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M805878200</ArticleId><ArticleId IdType="pmc">PMC2605999</ArticleId><ArticleId IdType="pubmed">18974049</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheli Y, et al. Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells. Oncogene. 2012;31:2461&#x2013;2470. doi: 10.1038/onc.2011.425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2011.425</ArticleId><ArticleId IdType="pubmed">21996743</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero S, et al. Gold nanoparticles as tracking devices to shed light on the role of caveolin-1 in early stages of melanoma metastasis. Nanomedicine (Lond.) 2018;13:1447&#x2013;1462. doi: 10.2217/nnm-2017-0390.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/nnm-2017-0390</ArticleId><ArticleId IdType="pubmed">29972676</ArticleId></ArticleIdList></Reference><Reference><Citation>Maxwell PH, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999;399:271&#x2013;275. doi: 10.1038/20459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/20459</ArticleId><ArticleId IdType="pubmed">10353251</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendoza P, Diaz J, Torres VA. On the role of Rab5 in cell migration. Curr. Mol. Med. 2014;14:235&#x2013;245. doi: 10.2174/1566524014666140128111347.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1566524014666140128111347</ArticleId><ArticleId IdType="pubmed">24467205</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandri C, et al. The R-Ras/RIN2/Rab5 complex controls endothelial cell adhesion and morphogenesis via active integrin endocytosis and Rac signaling. Cell Res. 2012;22:1479&#x2013;1501. doi: 10.1038/cr.2012.110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2012.110</ArticleId><ArticleId IdType="pmc">PMC3463263</ArticleId><ArticleId IdType="pubmed">22825554</ArticleId></ArticleIdList></Reference><Reference><Citation>Schodel J, et al. High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq. Blood. 2011;117:e207&#x2013;217. doi: 10.1182/blood-2010-10-314427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2010-10-314427</ArticleId><ArticleId IdType="pmc">PMC3374576</ArticleId><ArticleId IdType="pubmed">21447827</ArticleId></ArticleIdList></Reference><Reference><Citation>Barr F, Lambright DG. Rab GEFs and GAPs. Curr. Opin. Cell Biol. 2010;22:461&#x2013;470. doi: 10.1016/j.ceb.2010.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceb.2010.04.007</ArticleId><ArticleId IdType="pmc">PMC2929657</ArticleId><ArticleId IdType="pubmed">20466531</ArticleId></ArticleIdList></Reference><Reference><Citation>Langemeyer L, Frohlich F, Ungermann C. Rab GTPase function in endosome and lysosome biogenesis. Trends Cell Biol. 2018;28:957&#x2013;970. doi: 10.1016/j.tcb.2018.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2018.06.007</ArticleId><ArticleId IdType="pubmed">30025982</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai H, et al. ALS2/alsin knockout mice and motor neuron diseases. Neurodegener. Dis. 2008;5:359&#x2013;366. doi: 10.1159/000151295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000151295</ArticleId><ArticleId IdType="pmc">PMC2556598</ArticleId><ArticleId IdType="pubmed">18714162</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadano S, Kunita R, Otomo A, Suzuki-Utsunomiya K, Ikeda JE. Molecular and cellular function of ALS2/alsin: implication of membrane dynamics in neuronal development and degeneration. Neurochem. Int. 2007;51:74&#x2013;84. doi: 10.1016/j.neuint.2007.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2007.04.010</ArticleId><ArticleId IdType="pubmed">17566607</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunita R, et al. Homo-oligomerization of ALS2 through its unique carboxyl-terminal regions is essential for the ALS2-associated Rab5 guanine nucleotide exchange activity and its regulatory function on endosome trafficking. J. Biol. Chem. 2004;279:38626&#x2013;38635. doi: 10.1074/jbc.M406120200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M406120200</ArticleId><ArticleId IdType="pubmed">15247254</ArticleId></ArticleIdList></Reference><Reference><Citation>Otomo A, et al. ALS2, a novel guanine nucleotide exchange factor for the small GTPase Rab5, is implicated in endosomal dynamics. Hum. Mol. Genet. 2003;12:1671&#x2013;1687. doi: 10.1093/hmg/ddg184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddg184</ArticleId><ArticleId IdType="pubmed">12837691</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato K, et al. Altered oligomeric states in pathogenic ALS2 variants associated with juvenile motor neuron diseases cause loss of ALS2-mediated endosomal function. J. Biol. Chem. 2018;293:17135&#x2013;17153. doi: 10.1074/jbc.RA118.003849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.003849</ArticleId><ArticleId IdType="pmc">PMC6222102</ArticleId><ArticleId IdType="pubmed">30224357</ArticleId></ArticleIdList></Reference><Reference><Citation>Morishita S, Wada N, Fukuda M, Nakamura T. Rab5 activation on macropinosomes requires ALS2, and subsequent Rab5 inactivation through ALS2 detachment requires active Rab7. FEBS Lett. 2019;593:230&#x2013;241. doi: 10.1002/1873-3468.13306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.13306</ArticleId><ArticleId IdType="pubmed">30485418</ArticleId></ArticleIdList></Reference><Reference><Citation>Otomo A, Kunita R, Suzuki-Utsunomiya K, Ikeda JE, Hadano S. Defective relocalization of ALS2/alsin missense mutants to Rac1-induced macropinosomes accounts for loss of their cellular function and leads to disturbed amphisome formation. FEBS Lett. 2011;585:730&#x2013;736. doi: 10.1016/j.febslet.2011.01.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2011.01.045</ArticleId><ArticleId IdType="pubmed">21300063</ArticleId></ArticleIdList></Reference><Reference><Citation>Otomo A, et al. ALS2/alsin deficiency in neurons leads to mild defects in macropinocytosis and axonal growth. Biochem. Biophys. Res. Commun. 2008;370:87&#x2013;92. doi: 10.1016/j.bbrc.2008.01.177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2008.01.177</ArticleId><ArticleId IdType="pubmed">18358238</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunita R, et al. The Rab5 activator ALS2/alsin acts as a novel Rac1 effector through Rac1-activated endocytosis. J. Biol. Chem. 2007;282:16599&#x2013;16611. doi: 10.1074/jbc.M610682200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M610682200</ArticleId><ArticleId IdType="pubmed">17409386</ArticleId></ArticleIdList></Reference><Reference><Citation>Palamidessi A, et al. Endocytic trafficking of Rac is required for the spatial restriction of signaling in cell migration. Cell. 2008;134:135&#x2013;147. doi: 10.1016/j.cell.2008.05.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.05.034</ArticleId><ArticleId IdType="pubmed">18614017</ArticleId></ArticleIdList></Reference><Reference><Citation>Arany Z, et al. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature. 2008;451:1008&#x2013;1012. doi: 10.1038/nature06613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06613</ArticleId><ArticleId IdType="pubmed">18288196</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi AY, Waypa GB, Mungai PT, Schumacker PT. Prolonged hypoxia increases ROS signaling and RhoA activation in pulmonary artery smooth muscle and endothelial cells. Antioxid. Redox Signal. 2010;12:603&#x2013;610. doi: 10.1089/ars.2009.2861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2009.2861</ArticleId><ArticleId IdType="pmc">PMC2861537</ArticleId><ArticleId IdType="pubmed">19747063</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J, Handschin C, Spiegelman BM. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 2005;1:361&#x2013;370. doi: 10.1016/j.cmet.2005.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2005.05.004</ArticleId><ArticleId IdType="pubmed">16054085</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi Y, Takahashi S, Shiga Y, Yoshimi T, Miura T. Hypoxic induction of prolyl 4-hydroxylase alpha (I) in cultured cells. J. Biol. Chem. 2000;275:14139&#x2013;14146. doi: 10.1074/jbc.275.19.14139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.275.19.14139</ArticleId><ArticleId IdType="pubmed">10799490</ArticleId></ArticleIdList></Reference><Reference><Citation>Yatabe N, et al. HIF-1-mediated activation of telomerase in cervical cancer cells. Oncogene. 2004;23:3708&#x2013;3715. doi: 10.1038/sj.onc.1207460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1207460</ArticleId><ArticleId IdType="pubmed">15048086</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>